The influence of the immunosuppressants OKT3 and ATG on immunological parameters

被引:0
作者
Neumann, MC
Muller, TF
Sprenger, H
Gemsa, D
Lange, H
机构
[1] UNIV MARBURG,ZENTRUM INNERE MED,NEPHROL ABT,D-35033 MARBURG,GERMANY
[2] UNIV MARBURG,INST IMMUNOL,D-35033 MARBURG,GERMANY
关键词
transplantation; acute rejection; immune mediators; antibody therapy;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cytokines play an important role in the immune response induced by organ grafting, particularly during episodes of rejection. We tested the influence of monoclonal and polyclonal antibodies upon levels of mediators of the immune system. In 29 patients various cytokines and mediators were serially analyzed following transplantation. Thirteen patients received polyclonal antibodies (ATG) and 7 monoclonal (OKT3). Both OKT3 and ATG induced a rise in body temperature. Mean serum levels of amyloid A, neopterin, plasma levels of TNF alpha, interleukin 2 receptor (IL-2R) and urine levels of interleukin 6 (IL-6) and IL-2R were elevated when antibodies were employed. Interestingly, urine and plasma TNF-alpha as well as urine IL-6 and IL-2R remained elevated following ATG but not OKT3 and did not rise in case of basic treatment. In summary, antibody therapy increased levels of immune mediators. These mediators remained elevated following the discontinuation of treatment in case of ATG but not OKT3.
引用
收藏
页码:345 / 348
页数:4
相关论文
共 19 条
[1]   RELEASE OF TUMOR NECROSIS FACTOR, INTERLEUKIN-2, AND GAMMA-INTERFERON IN SERUM AFTER INJECTION OF OKT3 MONOCLONAL-ANTIBODY IN KIDNEY-TRANSPLANT RECIPIENTS [J].
ABRAMOWICZ, D ;
SCHANDENE, L ;
GOLDMAN, M ;
CRUSIAUX, A ;
VEREERSTRAETEN, P ;
DEPAUW, L ;
WYBRAN, J ;
KINNAERT, P ;
DUPONT, E ;
TOUSSAINT, C .
TRANSPLANTATION, 1989, 47 (04) :606-608
[2]   IMMUNOLOGICAL MONITORING AND EARLY PREDICTION OF REJECTION IN RENAL-ALLOGRAFT RECIPIENTS [J].
ATTALLAH, AM ;
ABDELGHAFFAR, H ;
ALGHRAOUI, F ;
FAWZY, A ;
ALIJANI, MR ;
MAHMOUD, LA ;
GHONEIM, MA ;
HELFRICH, GB .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1987, 84 (01) :10-17
[3]  
Auchincloss H., 1989, FUNDAMENTAL IMMUNOLO, P889
[4]  
BEUTLER B, 1987, NEW ENGL J MED, V316, P379
[5]   INVIVO CELL ACTIVATION FOLLOWING OKT3 ADMINISTRATION - SYSTEMIC CYTOKINE RELEASE AND MODULATION BY CORTICOSTEROIDS [J].
CHATENOUD, L ;
FERRAN, C ;
LEGENDRE, C ;
THOUARD, I ;
MERITE, S ;
REUTER, A ;
GEVAERT, Y ;
KREIS, H ;
FRANCHIMONT, P ;
BACH, JF .
TRANSPLANTATION, 1990, 49 (04) :697-702
[6]  
COLVIN RB, 1989, TRANSPLANT P, V21, P1863
[7]   EVIDENCE OF INVOLVEMENT OF TUMOR NECROSIS FACTOR IN ADVERSE REACTIONS DURING TREATMENT OF KIDNEY ALLOGRAFT-REJECTION WITH ANTITHYMOCYTE GLOBULIN [J].
DEBETS, JMH ;
LEUNISSEN, KML ;
VANHOOFF, HJ ;
VANDERLINDEN, CJ ;
BUURMAN, WA .
TRANSPLANTATION, 1989, 47 (03) :487-492
[8]   EVALUATION OF SEQUENTIAL PLASMA AND URINARY TUMOR-NECROSIS-FACTOR-ALPHA LEVELS IN RENAL-ALLOGRAFT RECIPIENTS [J].
MCLAUGHLIN, PJ ;
AIKAWA, A ;
DAVIES, HM ;
WARD, RG ;
BAKRAN, A ;
SELLS, RA ;
JOHNSON, PM .
TRANSPLANTATION, 1991, 51 (06) :1225-1229
[9]  
MULLER T, 1992, TRANSPLANT P, V24, P2731
[10]  
MULLER T, 1991, INT S TRANSPL MON JE